Pediatric Transplantation

Article	Citations
The pediatric solid organ transplant experience with COVID‐19: An initial multi‐center, multi‐organ case series	52
A case of an Infant with SARS‐CoV‐2 hepatitis early after liver transplantation	38
Pediatric cardiac waitlist mortality—Still too high	30
Attitudes toward xenotransplantation: A survey of parents and pediatric cardiac providers	28
Psychological functioning and psychosocial issues in pediatric kidney transplant recipients	22
Donor‐derived cell‐free DNA (dd‐cfDNA) for detection of allograft rejection in pediatric kidney transplants	21
Varying presentations of COVID‐19 in young heart transplant recipients: A case series	20
Clinical practice recommendations for recurrence of focal and segmental glomerulosclerosis/steroid‐resistant nephrotic syndrome	18
Treatment of post‐transplant lymphoproliferative disorder (PTLD) in a heart transplant recipient with chimeric antigen receptor T‐cell therapy	16
Low renal transplantation rates in children with end‐stage kidney disease: A study of barriers in a low‐resource setting	16
Nocturnal hypertension and left ventricular hypertrophy in pediatric renal transplant recipients in South India	15
The gut microbiome in solid organ transplantation	15
Low psoas muscle index as an unfavorable factor in children with end‐stage liver disease undergoing liver transplantation	14
Genetic disease and intellectual disability as contraindications to transplant listing in the United States: A survey of heart, kidney, liver, and lung transplant programs	14
De novo collapsing glomerulopathy in a pediatric kidney transplant recipient with COVID‐19 infection	13
Effects of donor cause of death, ischemia time, inotrope exposure, troponin values, cardiopulmonary resuscitation, electrocardiographic and echocardiographic data on recipient outcomes: A review of th	13
Autosomal dominant hyper‐IgE syndrome: When hematopoietic stem cell transplantation should be considered?	13
Restoration of nocturnal blood pressure dip and reduction of nocturnal blood pressure with evening anti‐hypertensive medication administration in pediatric kidney transplant recipients: A pilot random	13
A single‐center report of COVID‐19 disease course and management in liver transplanted pediatric patients	13
Impact of sarcopenia in infants with liver transplantation for biliary atresia	13
Initial posaconazole dosing to achieve therapeutic serum posaconazole concentrations among children, adolescents, and young adults receiving delayed‐release tablet and intravenous posaconazole	13
Variability in clinical decision‐making for ventricular assist device implantation in pediatrics	12
COVID‐19 infection in pediatric solid organ transplant patients	12
Post‐traumatic stress as a determinant of quality of life in pediatric solid‐organ transplant recipients	12
To treat or not to treat: CFTR modulators after lung transplantation	12

Factors associated with long‐term graft survival in pediatric kidney transplant recipients	12
Cytomegalovirus infection and allograft rejection among pediatric heart transplant recipients in the era of valganciclovir prophylaxis	12
Stable liver graft post anti‐PD1 therapy as a bridge to transplantation in an adolescent with hepatocellular carcinoma	11
The immune system in infants: Relevance to xenotransplantation	11
Determinants of length of stay after pediatric liver transplantation	11
Early findings after integration of donor‐derived cell‐free DNA into clinical care following pediatric heart transplantation	11
Religious and cultural aspects of organ donation: Narrowing the gap through understanding different religious beliefs	11
Luminal preloading with hydrogen‐rich saline ameliorates ischemia‐reperfusion injury following intestinal transplantation in rats	11
Augmented immunosuppression and PTCY‐based haploidentical hematopoietic stem cell transplantation for thalassemia major	10
Ibrutinib for the treatment of chronic graft‐vs‐host disease in pediatric hematopoietic stem cell transplant patients: A single‐center experience	10
Health literacy and its association with adherence in pediatric liver transplant recipients and their parents	10
State of pediatric liver transplantation in the United States and achieving zero wait list mortality with ideal outcomes: A statement from the Starzl Network for Excellence in Pediatric Transplant Sur	10
Transient elastography assessment of liver allograft fibrosis in pediatric transplant recipients	10
Multicenter data to improve health for pediatric renal transplant recipients in North America: Complementary approaches of NAPRTCS and IROC	10
Outflow vein venoplasty of left lateral section graft for living donor liver transplantation in infant recipients	10
Review of interactions between high‐risk pediatric heart transplant recipients and marginal donors including utilization of risk score models	10
Psychosocial situation, adherence, and utilization of video consultation in young adult long‐term pediatric liver transplant recipients during COVID‐19 pandemic	10
Promoting medication adherence from the perspective of adolescent and young adult kidney transplant recipients, parents, and health care professionals: A TAKE‐IT TOO study	10
Squamous cell carcinoma development in Fanconi anemia patients who underwent hematopoietic stem cell transplantation	9
Induction and maintenance immunosuppression in pediatric kidney transplantation—Advances and controversies	9
Physical activity and its correlates in a pediatric solid‐organ transplant population	9
Efficacy and feasibility of ruxolitinib in chronic steroid‐refractory GVHD in a pediatric intestine transplant	9
Presentation and outcomes of post‐transplant lymphoproliferative disorder at a single institution pediatric transplant center	9
Understanding disparities and barriers associated with pediatric transplant evaluation and time to listing: Moving toward a more comprehensive picture	9
Update on COVID‐19 vaccination in pediatric solid organ transplant recipients	9
Brincidofovir for the treatment of human adenovirus infection in pediatric solid organ transplant recipients: A case series	9
A community divided: Post‐transplant live vaccine practices among Society of Pediatric Liver Transplantation (SPLIT) centers	9
Use of a donor‐derived cell‐free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection	9
SARS‐CoV‐2 viral clearance during bone marrow aplasia after allogeneic hematopoietic stem cell transplantation—A case report	9
The case against COVID‐19 vaccine mandates in pediatric solid organ transplantation	9
Acute kidney injury and chronic kidney disease after non‐kidney solid organ transplantation	9
Fontan‐associated plastic bronchitis waitlist and heart transplant outcomes: A PHTS analysis	8
Surgical complications in pediatric kidney transplantation—Incidence, risk factors, and effects on graft survival: A retrospective single‐center study	8
Family functioning in pediatric heart transplantation: Variables associated with poor outcomes	8
Long‐term outcome after liver transplantation in children with type 1 glycogen storage disease	8
Examining racial and socioeconomic disparity in the pediatric heart transplant evaluation	8
Induction regimens and post‐transplantation lymphoproliferative disorder after pediatric intestinal transplantation: Single‐center experience	8
Review of the discard and/or refusal rate of offered donor hearts to pediatric waitlisted candidates	8
C1q‐binding DSA and allograft outcomes in pediatric kidney transplant recipients	8
Impact of tacrolimus variability on pediatric heart transplant outcomes	8
Kidney transplantation in children with CAKUT and non‐CAKUT causes of chronic kidney disease: Do they have the same outcomes?	8
Liver transplant in a recently COVID‐19 positive child with hepatoblastoma	8
Review of the impact of donor characteristics on pediatric heart transplant outcomes	8
Treatment of BK virus with a stepwise immunosuppression reduction and intravenous immunoglobulin in pediatric kidney transplant	8
Successful liver transplantation in short telomere syndromes without bone marrow failure due to DKC1 mutation	8
The kidney allocation system and pediatric transplantation at 5 years	7
Large for size in pediatrics liver transplant using left lateral segment grafts: A single center experience	7
Long‐term liver transplant outcomes for progressive familial intrahepatic cholestasis type 1: The Pittsburgh experience	7
An appraisal of technical variant grafts compared to whole liver grafts in pediatric liver transplant recipients: Multicenter analysis from the SPLIT registry	7
Usability of intraoperative cine‐portogram during liver transplantation in young pediatric patients with biliary atresia	7

Empowering patients to adhere to their treatment regimens: A multifaceted approach	7
A multicenter survey on post‐transplant lymphoproliferative disorders in pediatric heart transplant recipients: A case for development of consensus guidelines for screening, surveillance, and treatmen	7
Post‐transplant malignancies in pediatric organ transplant recipients	7
Bortezomib for autoimmune hemolytic anemia after intestinal transplantation	7
Pediatric liver transplantation from a living donor in mitochondrial disease: Good outcomes in DGUOK deficiency?	7
Paediatric kidney transplantation: Towards a framework for pretransplant urological evaluation	7
Age‐ and sex‐mediated differences in T lymphocyte populations of kidney transplant recipients	7
Risk factors for secondary poor graft function after bone marrow transplantation in children with acquired aplastic anemia	7
Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation in children: Single‐centre experience	7
Living donor liver transplantation for hepatic malignancies in children	7
Learning networks in pediatric heart failure and transplantation	7
A comprehensive strategy in donor acceptance: Impact on pediatric waitlist and heart transplant outcomes	7
Epstein–Barr virus‐associated risk factors for post‐transplant lymphoproliferative disease in pediatric liver transplant recipients	7
Exploring the potential for online peer support mentorship: Perspectives of pediatric solid organ transplant patients	7
Symptom‐orientated oral hygiene for children after heart transplantation: Effectiveness of a standardized prophylactic program	7
Pediatric donor heart allocation in the United States, 2006‐2017: Current patterns and potential for improvement	7
The potential of genetically engineered pig heart transplantation in infants with complex congenital heart disease	7
Robotic monosegment donor hepatectomy for pediatric liver transplantation: First report	7
COVID‐19 infection in a pediatric kidney transplant population: A single‐center experience	7
Isolated nocturnal hypertension in pediatric kidney transplant recipients	7
Management and outcome of hepatic artery thrombosis after pediatric liver transplantation	7
Care processes and structures associated with higher medication adherence in adolescent and young adult transplant recipients	7
Outcomes of allogeneic transplantation for hemoglobin Bart’s hydrops fetalis syndrome in Hong Kong	7
A multidisciplinary approach to improving transition readiness in pediatric liver transplant recipients	6
Reflecting on patient‐generated photographs of the pediatric renal transplant experience	6
Acute kidney disease predicts chronic kidney disease in pediatric non‐kidney solid organ transplant patients	6
Early surveillance biopsy utilization and management of pediatric renal allograft acute T cell–mediated rejection in Canadian centers: Observations from the PROBE multicenter cohort study	6
Kidney transplantation in low weight pediatric recipients from adult donors: The short‐ And the long‐term outcomes	6
Reducing the wait: TCV can expand the donor pool for heart transplant candidates	6
Safety of LAVs administered after pediatric LT	6
A systematic review of social determinants of health in pediatric organ transplant outcomes	6
Preoperative echocardiographic parameters predict primary graft dysfunction following pediatric lung transplantation	6
Illness perceptions and beliefs about medication: impact on health‐related quality of life in adolescent kidney transplant recipients	6
Outcomes of liver transplantation for mitochondrial respiratory chain disorder in children	6
Combined lung and liver transplantation for noncirrhotic portal hypertension with severe hepatopulmonary syndrome in a patient with dyskeratosis congenita	6
Outcome after pediatric liver transplantation for staged abdominal wall closure with use of biological mesh—Study with long‐term follow‐up	6
Hepatic artery reconstruction using an operating microscope in pediatric liver transplantation—Is it worth the effort?	6
Pediatric kidney transplant in undocumented immigrants: An American perspectives	6
Early school‐age cognitive performance post–pediatric heart transplantation	6
Adherence to laboratory testing in pediatric liver transplant recipients	6
Liver failure and x‐linked immunodeficiency type 47	6
Percutaneous transhepatic interventional therapy of portal vein stenosis in paediatric liver transplantation: A systematic review of efficacy and safety	6
Changing racial and ethnic differences for lung transplantation in cystic fibrosis	6
Management and prevention of varicella and measles infections in pediatric solid organ transplant candidates and recipients: An IPTA survey of current practice	6
Impact of mechanical circulatory support on survival in pediatric heart transplantation	6
The extracorporeal circulation with transdiaphragmatic approach in living‐donor liver transplantation for HB with atrial extension of tumor thrombus: A case report	6
Paraneoplastic pemphigus associated with post‐transplant lymphoproliferative disorder after small bowel transplantation	6
Prophylactic antithrombotic management in adult and pediatric kidney transplantation: A systematic review and meta‐analysis	6
Examining the association of medical complications and posttraumatic stress symptoms in pediatric solid organ transplant patients and their caregivers	6
Interplay between donor and recipient factors impacts outcomes after pediatric heart transplantation: An analysis from the united network for organ sharing database	6
Practice variation in the immediate postoperative care of pediatric liver transplant patients: Framework for a national consensus	6
CMV infection and management among pediatric solid organ transplant recipients	6
Pediatric kidney transplantation in Egypt: Results of 10‐year single‐center experience	6
Comparative outcome analysis of pediatric kidney transplant in posterior urethral valves children with or without pretransplant Mitrofanoff procedure	6
Declining mortality rates in children admitted to ICU following HCT	6
Comparison of cystatin C, creatinine, and iohexol clearance in pediatric liver transplantation—a retrospective cohort study	6
Current practice of antithrombotic prophylaxis in pediatric kidney transplantation—Results of an international survey on behalf of the European Society for Paediatric Nephrology	6
Do funding sources influence long‐term patient survival in pediatric liver transplantation?	6
Timing of native nephrectomy and kidney transplant outcomes in children	5
Ventricular assist device support for children with chemotherapy‐induced cardiomyopathy and advanced heart failure: Perspectives gained from a single‐center experience	5
Our evolution in the treatment of hepatic artery and portal vein thrombosis in pediatric liver transplantation: Success with catheter‐directed therapies	5
Multi‐organism gastrointestinal polymerase chain reaction positivity among pediatric transplant vs non‐transplant populations: A single‐center experience	5
Full left/full right liver graft ex situ split during hypothermic oxygenated perfusion	5
Immediate extubation following pediatric liver transplantation	5
Early hepatic arterial thrombosis in liver transplantation: Systemic intravenous alteplase as a potential rescue treatment after failed surgical revascularization	5
Domino transplantation for pediatric liver recipients: Obstacles, challenges, and successes	5
Paediatric deceased donor kidney transplant in Australia: A 30‐year review—What have paediatric bonuses achieved and where to from here?	5
Use of eltrombopag for the treatment of poor graft function after hematopoietic stem cell transplantation in children	5
School and sports participation post‐transplant	5
Long‐term psychosocial outcomes of adults transplanted in childhood: A social work perspective	5
Incidence and risk factors of kidney allograft loss due to BK nephropathy in the pediatric population: A retrospective analysis of the UNOS/OPTN database	5
Minding the gap—Providing quality transplant care for South African children with acute liver failure	5
Unmanipulated haploidentical hematopoietic stem cell transplantation for children with myelodysplastic syndrome	5
Motor outcomes in young children pre‐and one‐year post‐liver transplant	5
Non‐operative management of biliary complications after Liver Transplantation in pediatric patients: A 30‐year experience	5
Use of Rituximab for persistent EBV DNAemia, and Its effect on donor‐specific antibody development in pediatric renal transplant recipients: A case series	5
Variation in immunosuppression practices among pediatric liver transplant centers—Society of Pediatric Liver Transplantation survey results	5
Decreased access to pediatric liver transplantation during the COVID‐19 pandemic	5
Awareness and concerns about novel coronavirus disease 2019 (COVID‐19) among parents of pediatric liver transplant recipients	5
Characteristics, risk factors, and outcomes of neutropenia after liver or kidney transplantation in children	5

Experience of the first 6 years of pediatric kidney transplantation in Indonesia: A multicenter retrospective study	5
Post‐operative fluid overload as a predictor of hospital and long‐term outcomes in a pediatric heart transplant population	5
Psychosocial outcomes in pediatric patients with ventricular assist devices and their families: A systematic review	5
Clinical Efficacy of Ruxolitinib Monotherapy and Haploidentical Hematopoeitic Stem Cell Transplantation in a Child with Philadelphia Chromosome‐like Relapsed/Refractory acute lymphoblastic leukemia	5
A case of treatment‐resistant membranous nephropathy associated with graft versus host disease successfully treated with daratumumab	5
The current state of pediatric transplant hepatology fellowships: A survey of recent graduates	5
The mental health profiles of pediatric organ transplant recipients	5
T cell phenotype in paediatric heart transplant recipients	5
Allogeneic hematopoietic stem cell transplantation from sibling and unrelated donors in pediatric patients with sickle cell disease—A single center experience	5
Kidney transplantation with allografts from infant donors—Small organs, big value	5
Conversion from tacrolimus to sirolimus as a treatment modality in de novo allergies and immune‐mediated disorders in pediatric liver transplant recipients	5
Approaches to safe living and diet after solid organ transplantation	5
Heterogeneous outcomes of liver disease after heart transplantation for a failed Fontan procedure	5
Predictors of portal vein complications after pediatric liver transplantation: A German center experience	5
Post Transplant Lymphoproliferative Disorder risk factors in children: Analysis of a 23‐year single‐institutional experience	5
Hematopoietic stem cell transplantation in serine/threonine kinase 4 (STK4) deficiency: Report of two cases and literature review	5
Successful kidney transplantation in a patient with neonatal‐onset ILNEB	5
SARS‐CoV‐2 and pediatric solid organ transplantation: Current knowns and unknowns	5
Factors affecting survival in children requiring intensive care after hematopoietic stem cell transplantation. A retrospective single‐center study	5
Non‐HLA AT1R antibodies are highly prevalent after pediatric intestinal transplantation	5
Allogeneic hematopoietic stem cell transplant in pediatric acute myeloid leukemia: Lessons learnt from a tertiary care center in India	5
Rejection surveillance in pediatric heart transplant recipients: Critical reflection on the role of frequent and long‐term routine surveillance endomyocardial biopsies and comprehensive review of non‐	5
Diagnostic performance of 2D‐shear wave elastography and serum fibrosis markers for evaluation of hepatic graft fibrosis in pediatric liver‐inclusive transplant recipients: A prospective pilot study	5
Diarrhea in the pediatric solid organ transplantation recipient: A multidisciplinary approach to diagnosis and management	5
Human leukocyte antigen eplet mismatches and long‐term clinical outcomes in pediatric renal transplantation: A pragmatic, registry‐based study	5
Long‐term mortality in pediatric solid organ recipients—A nationwide study	5
Comparison of pediatric brain‐dead donors to donation after circulatory death donors in the United States	5
Time is of the essence: A single‐center experience of hepatic arterial supply impairment management in pediatric liver transplant recipients	5
Re‐hospitalization after pediatric kidney transplant: A single‐center study	4
Bartonella henselae infection in the pediatric solid organ transplant recipient	4
Permanent pacemaker implantation in pediatric heart transplant recipients: A systematic review and evidence quality assessment	4
Incidence of cytomegalovirus DNAemia in pediatric kidney, liver, and heart transplant recipients: Efficacy and risk factors associated with failure of weight‐based dosed valganciclovir prop	4
Course of renal allograft function after diagnosis and treatment of post‐transplant lymphoproliferative disorders in pediatric kidney transplant recipients	4
Course of vitamin D levels before and after liver transplantation in pediatric patients	4
Complications of Cryptosporidium infection after pediatric liver transplantation: Diarrhea, rejection, and biliary disease	4
Impact of immediate post‐transplant parenteral iron therapy on the prevalence of anemia and short‐term allograft function in a cohort of pediatric and adolescent renal transplant recipients	4
Promoting cardiovascular health post‐transplant through early diagnosis and adequate management of hypertension and dyslipidemia	4
Utility of pre‐transplant lower urinary tract investigation in pediatric renal transplant population after referral: A 16‐year institutional experience	4
Cardiac allograft vasculopathy: A review	4
Treatment adherence and behavior of pediatric liver transplant recipients during the COVID‐19 pandemic	4
Surgical technique and the long‐term outcomes of pediatric living donor domino liver transplantation from patients with maple syrup urine disease	4
Operational tolerance after pediatric composite liver‐pancreas‐intestine transplantation following severe graft‐versus‐host disease	4
Pediatric hematopoietic cell transplantation: Longitudinal trends in body mass index and outcomes	4
Vitamin D has no impact on outcomes after HSCT in children—A retrospective study	4
What is the long‐term outlook for young people following liver transplant? A single‐centre retrospective analysis of physical and psychosocial outcomes	4
Pericardial effusion following hematopoietic stem cell transplantation in children: Incidence, risk factors, and outcomes	4
Reappraisal of liver transplantation for erythropoietic protoporphyria: A deadly combination of disease recurrence and biliary complication	4
Efficacy of intraoperative cine‐portogram for complicated portal vein reconstruction in pediatric living donor liver transplantation	4
Mismatch epitope load predicts de novo‐DSA‐free survival in pediatric liver transplantation	4
Understanding Substance use Policies and Associated Ethical Concerns: A survey of Pediatric Transplant Centers	4
Impact of length of donor ICU stay on outcome of patients after pediatric liver transplantation with whole and in situ split liver grafts	4
Impact of institutional routine surveillance endomyocardial biopsy frequency in the first year on rejection and graft survival in pediatric heart transplantation	4
Incidence of thyroid dysfunction in children after HSCT with reduced intensity conditioning (RIC) or myeloablative conditioning (MAC)	4
Preparing for a kidney transplant: Medical nephrectomy in children with nephrotic syndrome	4
Quality of life in long term survivors of pediatric intestinal transplantation compared with liver transplantation and home parenteral nutrition: A prospective single‐center pilot study	4
An ethical analysis of obesity as a determinant of pediatric heart transplant candidacy	4
Abstract Supplement	4
Low CD4 count may be a risk factor for non‐tuberculous mycobacteria infection in pediatric hematopoietic cell transplant recipients	4
CD34+ selected peripheral blood Stem Cell Boost (SCB) for Poor Graft Function (PGF) or mixed chimerism in pediatric patients, after hematopoietic stem cell transplantation: Results of a retrospective	4
Compare the performance of multiple machine learning models in predicting tacrolimus concentration for infant patients with living donor liver transplantation	4
A text messaging intervention and quality of life in adolescents with solid organ transplants	4
Steroid avoidance/withdrawal and maintenance immunosuppression in pediatric kidney transplantation	4
Comparative analysis of outcomes and long‐term follow‐up of robot‐assisted pediatric kidney transplantation, with open counterpart	4
Preparing for the 2020—2021 influenza season	4
A Neonatal ABO non‐compatible heart transplant from a circulatory‐determined death donor using NRP/Cold storage	4
Effect of magnification in pediatric liver transplantation: A systematic review and meta‐analysis	4
Pediatric liver transplantation in severe hepatopulmonary syndrome and use of inhaled nitric oxide for post‐transplant hypoxemia–a single center experience	4
Good outcomes after pediatric intraperitoneal kidney transplant	4
Allocation to pediatric recipients around the world: An IPTA global survey of current pediatric solid organ transplantation deceased donation allocation practices	4
Circumstances surrounding end‐of‐life in pediatric patients pre‐ and post‐heart transplant: a report from the Pediatric Heart Transplant Society	4
Patient and provider factors impacting referral for neonatal organ donation	4
Pediatric liver transplantation activity in a high‐volume program during the COVID‐19 pandemic in Brazil	4
Right heart failure considerations in pediatric ventricular assist devices	4
Repeated CD45RA‐depleted DLI successfully increases donor chimerism in a patient with beta‐thalassemia major after haploidentical stem cell transplant	4
Sequential paternal haploidentical donor liver and HSCT in EPP allow discontinuation of immunosuppression post‐organ transplant	4
Effect of ischemic time on pediatric heart transplantation outcomes: is it the same for all allografts?	4
Iron overload after allogeneic stem cell transplantation in children with acute lymphoblastic leukemia	4
Focal segmental glomerulosclerosis: Risk for recurrence and interventions to optimize outcomes following recurrence	4
Additional value of superb microvascular imaging for assessing hepatic arterial blood flow after pediatric liver transplantation	4
Pediatric lung transplant: Correlation of pretransplant condition with post‐transplant outcomes	4
Solid organ transplant–specific antibiogram in a tertiary pediatric hospital in Canada	4
Pediatric KT in children up to 15 kg: A single‐center experience	4
Ehrlichia‐induced hemophagocytic lymphohistiocytosis in a pediatric kidney transplant recipient	4
Spotting a potential threat: Measles among pediatric solid organ transplantation recipients	4
Percutaneous endovascular management of ascending aortic pseudoaneurysm after heart transplantation in a pediatric patient	4
Prospective Evaluation of the Fungitell® (1→3) Beta‐D‐Glucan Assay as a Diagnostic Tool for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplantation: A Report from	4
COVID‐19 vaccination in pediatric solid organ transplant recipients—Current state and future directions	4
Treprostinil improves hemodynamics and symptoms in children with mild pulmonary hypertension awaiting heart transplantation	4
Comparison of levetiracetam versus phenytoin/fosphenytoin for busulfan seizure prophylaxis at a pediatric institution	4
Relationship between donor fraction cell‐free DNA and clinical rejection in heart transplantation	4
The utility of native ureter in the management of ureteral complications in children after renal transplantation	4
Pediatric length‐of‐stay index following liver transplantation	4
The outcome and complications of total parenteral nutrition in pediatric hematopoietic stem cell transplantation	4
Pharmacokinetic analysis for model‐supported therapeutic drug monitoring of busulfan in Japanese pediatric hematopoietic stem cell transplantation recipients	4
Time to second kidney transplantation in young adults after failed pediatric kidney transplant	4